Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maroulio Pertesi

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Plos One|April 8, 2015
Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian populationStéphane Maillard, Francesca Damiola, Enora Clero, et al.
Plos One|March 29, 2013
Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer casesAlexandra V Stavropoulou, Florentia Fostira, Maroulio Pertesi, et al.
Oncotarget|October 6, 2016
KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-controlFlorence Le Calvez-Kelm, Matthieu Foll, Magdalena B Wozniak, et al.
Leukemia|November 18, 2025
Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset casesMaroulio Pertesi, Delphine Demangel, Abhishek Niroula, et al.
Breast Cancer Research and Treatment|March 22, 2012
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group StudyFlorentia Fostira, Marianthi Tsitlaidou, Christos Papadimitriou, et al.
BMC Genetics|April 17, 2015
Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban populationCelia M Pereda, Fabienne Lesueur, Maroulio Pertesi, et al.
Blood|January 10, 2022
Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levelsAitzkoa Lopez de Lapuente Portilla, Ludvig Ekdahl, Caterina Cafaro, et al.
Breast Cancer Research : BCR|June 5, 2014
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening studyFrancesca Damiola, Maroulio Pertesi, Javier Oliver, et al.
Blood Cancer Journal|April 20, 2021
Germline variants at SOHLH2 influence multiple myeloma riskLaura Duran-Lozano, Gudmar Thorleifsson, Aitzkoa Lopez de Lapuente Portilla, et al.
American Journal of Hematology|January 2, 2023
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome studyCharles Dumontet, Delphine Demangel, Perrine Galia, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Plos One|April 8, 2015
Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian populationStéphane Maillard, Francesca Damiola, Enora Clero, et al.
Plos One|March 29, 2013
Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer casesAlexandra V Stavropoulou, Florentia Fostira, Maroulio Pertesi, et al.
Oncotarget|October 6, 2016
KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-controlFlorence Le Calvez-Kelm, Matthieu Foll, Magdalena B Wozniak, et al.
Leukemia|November 18, 2025
Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset casesMaroulio Pertesi, Delphine Demangel, Abhishek Niroula, et al.
Breast Cancer Research and Treatment|March 22, 2012
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group StudyFlorentia Fostira, Marianthi Tsitlaidou, Christos Papadimitriou, et al.
BMC Genetics|April 17, 2015
Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban populationCelia M Pereda, Fabienne Lesueur, Maroulio Pertesi, et al.
Blood|January 10, 2022
Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levelsAitzkoa Lopez de Lapuente Portilla, Ludvig Ekdahl, Caterina Cafaro, et al.
Breast Cancer Research : BCR|June 5, 2014
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening studyFrancesca Damiola, Maroulio Pertesi, Javier Oliver, et al.
Blood Cancer Journal|April 20, 2021
Germline variants at SOHLH2 influence multiple myeloma riskLaura Duran-Lozano, Gudmar Thorleifsson, Aitzkoa Lopez de Lapuente Portilla, et al.
American Journal of Hematology|January 2, 2023
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome studyCharles Dumontet, Delphine Demangel, Perrine Galia, et al.
Pageof 3